Z. Kállay

440 total citations
38 papers, 371 citations indexed

About

Z. Kállay is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Physiology. According to data from OpenAlex, Z. Kállay has authored 38 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 7 papers in Pediatrics, Perinatology and Child Health and 7 papers in Physiology. Recurrent topics in Z. Kállay's work include Antibiotics Pharmacokinetics and Efficacy (9 papers), Drug Transport and Resistance Mechanisms (6 papers) and Pharmacological Effects and Toxicity Studies (5 papers). Z. Kállay is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (9 papers), Drug Transport and Resistance Mechanisms (6 papers) and Pharmacological Effects and Toxicity Studies (5 papers). Z. Kállay collaborates with scholars based in Slovakia, Germany and Japan. Z. Kállay's co-authors include T. Trnovec, S Bezek, Ladislav Šoltés, John M. Kovarik, Edgar A. Mueller, Klaus Kutz, Paul M. Tulkens, Bellamkonda Kishore, Peter Chabreček and Mária Ďurišová and has published in prestigious journals such as The American Journal of Cardiology, Journal of Pharmacology and Experimental Therapeutics and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Z. Kállay

38 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Z. Kállay Slovakia 11 72 51 51 49 49 38 371
J. Moppert Switzerland 11 76 1.1× 66 1.3× 134 2.6× 59 1.2× 37 0.8× 25 472
S. Halide Akbaş Türkiye 10 96 1.3× 27 0.5× 26 0.5× 47 1.0× 79 1.6× 16 355
P Riant France 12 116 1.6× 29 0.6× 92 1.8× 88 1.8× 16 0.3× 26 362
Jean Paul Tillement France 14 170 2.4× 135 2.6× 32 0.6× 31 0.6× 36 0.7× 22 491
H. Dutertre-Catella France 11 67 0.9× 32 0.6× 22 0.4× 73 1.5× 15 0.3× 26 323
Touraj Shokati United States 11 130 1.8× 37 0.7× 57 1.1× 25 0.5× 58 1.2× 23 372
Ryosei Kawai Japan 12 99 1.4× 30 0.6× 80 1.6× 108 2.2× 28 0.6× 17 488
W. D. Paul United States 12 127 1.8× 42 0.8× 37 0.7× 19 0.4× 15 0.3× 32 520
Dwight D. Stiff United States 13 158 2.2× 22 0.4× 51 1.0× 69 1.4× 22 0.4× 18 444
Paweł K. Kunicki Poland 10 59 0.8× 46 0.9× 94 1.8× 14 0.3× 125 2.6× 26 345

Countries citing papers authored by Z. Kállay

Since Specialization
Citations

This map shows the geographic impact of Z. Kállay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Z. Kállay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Z. Kállay more than expected).

Fields of papers citing papers by Z. Kállay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Z. Kállay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Z. Kállay. The network helps show where Z. Kállay may publish in the future.

Co-authorship network of co-authors of Z. Kállay

This figure shows the co-authorship network connecting the top 25 collaborators of Z. Kállay. A scholar is included among the top collaborators of Z. Kállay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Z. Kállay. Z. Kállay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wawruch, Martin, Gejza Wimmer, J. Luha, et al.. (2016). Factors Influencing Non-Persistence with Antiplatelet Medications in Elderly Patients After Ischaemic Stroke. Drugs & Aging. 33(5). 365–373. 13 indexed citations
2.
Wawruch, Martin, et al.. (2015). The use of antiplatelet medication in hospitalised elderly patients. Bratislavské lekárske listy/Bratislava medical journal. 116(9). 533–538. 3 indexed citations
3.
Kovarik, John M., Z. Kállay, Edgar A. Mueller, et al.. (1995). Acute effect of cyclosporin on renal function following the initial changeover to a microemulsion formulation in stable kidney transplant patients. Transplant International. 8(5). 335–339. 10 indexed citations
4.
Schmidt, Christoph, et al.. (1995). Pharmacokinetics of Orally Administered Cyclosporine in Patients with Crohn's Disease. The Journal of Clinical Pharmacology. 35(7). 681–687. 10 indexed citations
5.
Mueller, Edgar A., et al.. (1995). BILE-INDEPENDENT ABSORPTION OF CYCLOSPORINE FROM A MICROEMULSION FORMULATION IN LIVER TRANSPLANT PATIENTS. Transplantation. 60(5). 515–516. 36 indexed citations
6.
Appel, Silke, et al.. (1995). Lack of interaction between fluvastatin andoral nypoylycemie agents in healthy subjects and in patients with non-insulin-dependent diabetes mellitus. The American Journal of Cardiology. 76(1-2). 29A–32A. 35 indexed citations
7.
Kovarik, John M., Edgar A. Mueller, Z. Kállay, et al.. (1995). Concentration‐Guided Strategies in Drug Development: Experience with a Cyclosporine Analog in Transplantation. The Journal of Clinical Pharmacology. 35(12). 1136–1143. 3 indexed citations
8.
Kállay, Z., et al.. (1994). NG-nitro-L-arginine is not involved in enterohepatic cycling in rats.. Drug Metabolism and Disposition. 22(2). 338–339. 3 indexed citations
9.
Kállay, Z., et al.. (1994). Dose-ranging study ofNG-nitro-L-arginine pharmacokinetics in rats after bolus intravenous administration. Xenobiotica. 24(7). 663–669. 7 indexed citations
10.
Kállay, Z., et al.. (1993). The use of a nonlinear absorption model in the study of ascorbic acid bioavailability in man. Biopharmaceutics & Drug Disposition. 14(5). 429–442. 11 indexed citations
11.
Kállay, Z., et al.. (1993). NG-nitro-L-arginine pharmacokinetics in rats after a single intravascular and oral dose: an appearance of secondary concentration time peaks.. Drug Metabolism and Disposition. 21(5). 962–964. 12 indexed citations
12.
Kállay, Z., et al.. (1991). Evaluation of3H-CGP 12177 and3H-DHA Binding to β2-Adrenoceptors of Rat Reticulocytes by Means of Affinity Spectra. Journal of Receptor Research. 11(6). 909–917. 2 indexed citations
13.
Bauerová, Katarína, et al.. (1991). Determination of pentoxifylline in serum by high-performance thin-layer chromatography. Journal of Pharmaceutical and Biomedical Analysis. 9(3). 247–250. 8 indexed citations
14.
Šoltés, Ladislav, et al.. (1991). A high‐performance liquid chromatographic method for the determination of stobadin pharmacokinetics in serum. Biopharmaceutics & Drug Disposition. 12(1). 29–35. 10 indexed citations
15.
Bezek, S, et al.. (1990). Irradiation of the head by60Co opens the blood-brain barrier for drugs in rats. Cellular and Molecular Life Sciences. 46(10). 1017–1020. 11 indexed citations
16.
Trnovec, T., Z. Kállay, & S Bezek. (1990). Effects of ionizing radiation on the blood brain barrier permeability to pharmacologically active substances. International Journal of Radiation Oncology*Biology*Physics. 19(6). 1581–1587. 48 indexed citations
17.
Chabreček, Peter, Ladislav Šoltés, Z. Kállay, & Igor Novák. (1990). Gel permeation chromatographic characterization of sodium hyaluronate and its fractions prepared by ultrasonic degradation. Chromatographia. 30(3-4). 201–204. 22 indexed citations
18.
Kállay, Z., Mária Ďurišová, T. Trnovec, & V. Svoboda. (1990). Effect of gamma-irradiation on disposition of the local anaesthetic, carbisocaine in rabbits. Journal of Pharmacy and Pharmacology. 42(12). 871–873. 1 indexed citations
19.
Bezek, S, et al.. (1990). Disposition of ethimizol, a xanthine-related nootropic drug, in perfused rat liver and isolated hepatocytes.. Drug Metabolism and Disposition. 18(1). 88–95. 9 indexed citations
20.
Bezek, S, et al.. (1988). Pharmacokinetics of carbisocaine in rats and mice. European Journal of Drug Metabolism and Pharmacokinetics. 13(1). 27–34. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Moppert Breakdown of academic impact, for papers by S. Halide Akbaş Breakdown of academic impact, for papers by P Riant Breakdown of academic impact, for papers by Jean Paul Tillement Breakdown of academic impact, for papers by H. Dutertre-Catella Breakdown of academic impact, for papers by Touraj Shokati Breakdown of academic impact, for papers by Ryosei Kawai Breakdown of academic impact, for papers by W. D. Paul Breakdown of academic impact, for papers by Dwight D. Stiff Breakdown of academic impact, for papers by Paweł K. Kunicki
Rankless by CCL
2026